Publication:
El ácido ursodexosicólico disminuye el riesgo de mocroangiopatía trombótica tras traspante de progenitores hematopoyéticos

Loading...
Thumbnail Image

Date

2015-10-22

Authors

Ruiz Mercado, M
López Godino, O
Martínez, C
Solano, C
Parody, R
López Corral, L
Fernández-Avilés, F
Herrera, JC
Márquez-Malaver, FJ
Caballero, D

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Ferrata Storti Foundation
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Fundamentos y/o objetivos: La microangiopatía trombótica (MAT) es una complicación grave tras el trasplante alogénico de progenitores hematopoyéticos (AloTPH). El daño endotelial en la MAT se traduce en concentraciones elevadas de FvW o endotelina, entre otros. El ácido ursodesoxicólico (AU) ejerce una acción inmunomoduladora y anti-inflamatoria inhibiendo la endotelina y el NF-κb y promoviendo la producción de óxido nítrico. Con estas premisas, el objetivo del estudio fue analizar la incidencia y factores de riesgo de MAT e identificar el posible papel protector del AU en el desarrollo de MAT.

Description

LVII Congreso Nacional De La Sociedad Española De Hematología Y Hemoterapia, Valencia, Spain, 22–24 De Octubre, 2015

MeSH Terms

Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::DNA-Binding Proteins::NF-kappa B
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Acyclic::Alkenes::Polyenes::Carotenoids::Retinoids::Vitamin A::Tretinoin
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Inflammatory Agents
Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Endothelins
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Transplantation::Cell Transplantation::Stem Cell Transplantation::Hematopoietic Stem Cell Transplantation
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Incidence
Medical Subject Headings::Chemicals and Drugs::Inorganic Chemicals::Free Radicals::Nitric Oxide
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors
Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Blood Platelet Disorders::Thrombocytopenia::Thrombotic Microangiopathies
Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids::Bile Acids and Salts::Cholic Acids::Deoxycholic Acid::Ursodeoxycholic Acid

DeCS Terms

CIE Terms

Keywords

Microangiopatía trombótica, Progenitores hematopoyéticos, Endotelina, Óxido nítrico

Citation

Ruiz Mercado M, López Godino O, Martínez C, Solano C, Parody R, López Corral L, et al. El ácido ursodexosicólico disminuye el riesgo de mocroangiopatía trombótica tras traspante de progenitores hematopoyéticos. Haematologica.2015; vol.100, suplemt.4 , CO-073